Former Taiwanese National Academy Head Cleared of Corruption

Wong Chi-huey, who was the president of Academia Sinica until 2016, was found not guilty of taking bribes from a pharmaceutical company.

Written byAshley Yeager
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

ABOVE: A sign pointing to Academia Sinica
WIKIMEDIA, SOLOMON203

Biochemist Wong Chi-huey, the former president of Academia Sinica, the national academy in Taiwan, was cleared of corruption charges by the Shilin District Court last Friday (December 28).

“Despite that justice has been served, it does not recover (my) reputation,” Wong says in an article by Central News Agency, the government of the Republic of China’s state-owned news outlet, posted on Taiwan News.

The corruption investigation began in 2016 when the Shilin District Prosecutors’ Office started to look more closely at shares of a startup biotech company called OBI Pharma that Wong received from Michael Chang, the company’s chairman. Allegedly, the shares were given to Wong in exchange for him helping OBI obtain access to information from Academia Sinica on enzyme synthesis techniques. Wong and Chang were indicted a year ago under the Anti-Corruption Act and have now both been cleared of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies